title: Neural network cascade optimizes microRNA biomarker selection for nasopharyngeal cancer prognosis.
abstract: MicroRNAs (miRNAs) have been shown to be promising biomarkers in predicting cancer prognosis. However, inappropriate or poorly optimized processing and modeling of miRNA expression data can negatively affect prediction performance. Here, we propose a holistic solution for miRNA biomarker selection and prediction model building. This work introduces the use of a neural network cascade, a cascaded constitution of small artificial neural network units, for evaluating miRNA expression and patient outcome. A miRNA microarray dataset of nasopharyngeal carcinoma was retrieved from Gene Expression Omnibus to illustrate the methodology. Results indicated a nonlinear relationship between miRNA expression and patient death risk, implying that direct comparison of expression values is inappropriate. However, this method performs transformation of miRNA expression values into a miRNA score, which linearly measures death risk. Spearman correlation was calculated between miRNA scores and survival status for each miRNA. Finally, a nine-miRNA signature was optimized to predict death risk after nasopharyngeal carcinoma by establishing a neural network cascade consisting of 13 artificial neural network units. Area under the ROC was 0.951 for the internal validation set and had a prediction accuracy of 83% for the external validation set. In particular, the established neural network cascade was found to have strong immunity against noise interference that disturbs miRNA expression values. This study provides an efficient and easy-to-use method that aims to maximize clinical application of miRNAs in prognostic risk assessment of patients with cancer.
authors.affiliation: Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
authors.forename: Wenliang
authors.initials: W
authors.lastname: Zhu
authors.affiliation: Department of Otolaryngology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
authors.forename: Xuan
authors.initials: X
authors.lastname: Kan
mesh_terms: D015415:Biomarkers; D030561:Databases, Nucleic Acid; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D053263:Gene Regulatory Networks; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D008954:Models, Biological; D009303:Nasopharyngeal Neoplasms / Q000235:genetics* / Q000401:mortality*; D011379:Prognosis; D012372:ROC Curve; D015203:Reproducibility of Results
chemical_list: D015415:Biomarkers; D035683:MicroRNAs